The 20 Best Marginal Zone Lymphoma (MZL) Doctors Near Me in Altoona, PA
Find the Top Marginal Zone Lymphoma (MZL) Experts and Specialists
UPMC Hillman Cancer Center At UPMC Altoona
Mark Keating, MD, is a medical oncologist specializing in tumors and diseases of the blood. He has a particular expertise in the diagnosis and treatment of gastrointestinal, kidney, bladder, breast, lung, head and neck, and prostate cancers, as well as chronic leukemia, lymphoma, brain tumors, and benign hematologic disorders. Dr. Keating is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Paget Disease of the Breast, and Non-Hodgkin Lymphoma. Dr. Keating is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Keating is currently accepting new patients.
UPMC Hillman Cancer Center At UPMC Altoona
Joella Wilson, MD, specializes in radiation oncology and is board-certified by the American Board of Radiology. She is affiliated with UPMC Memorial, UPMC West Shore, UPMC Community Osteopathic, UPMC Harrisburg, UPMC Carlisle, UPMC Lititz, and UPMC Altoona. Dr. Wilson received her medical degree from the University of Kansas School of Medicine and completed residencies at the University of Texas Medical Branch at Galveston and Baylor College of Medicine. Dr. Wilson is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Wilson is board certified in American Board Of Radiology. Dr. Wilson is currently accepting new patients.
UPMC Hillman Cancer Center - Altoona
Michal Krauze, MD, PhD, is a medical oncologist at UPMC Hillman Cancer Center. He has a special interest in breast cancer, colon cancer, gastrointestinal oncology, thoracic oncology, lung cancer, genitourinary oncology, prostate cancer, and malignant hematology. Dr. Krauze is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Krauze is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Krauze is currently accepting new patients.
UPMC Hillman Cancer Center - Altoona
Kristopher Hansen, DO, specializes in hematology oncology and is board-certified in internal medicine and medical oncology by the American Board of Internal Medicine. He is affiliated with UPMC Altoona. Dr. Hansen completed his fellowship at the University of Kansas School of Medicine, residency at Wake Forest University School of Medicine and medical degree at Edward Via College of Osteopathic Medicine. Dr. Hansen is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome. Dr. Hansen is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Hansen is currently accepting new patients.
UPMC Altoona Radiology
Sergei Sobolevsky, MD, specializes in diagnostic radiology and is board-certified in interventional radiology and diagnostic radiology by the American Board of Radiology. He practices at UPMC Altoona Radiology. Dr. Sobolevsky completed his medical education at University of Colorado at Boulder, residency at Rutgers Robert Wood Johnson Medical School and State University of New York Downstate School of Medicine, and fellowship at Columbia University College of Physicians and Surgeons and Beth Israel Deaconess Medical Center. Dr. Sobolevsky is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Ascites, Colorectal Cancer, Familial Colorectal Cancer, Prostatic Artery Embolization, and Gastrostomy. Dr. Sobolevsky is board certified in American Board Of Radiology.
UPMC Hillman Cancer Center
Anna Lisa McGlinn, MD, specializes in radiation oncology and is board-certified by the American Board of Radiology. Dr. McGlinn received her medical degree from St. George's University School of Medicine and completed her residency at the University of Southern California Keck School of Medicine. Dr. Mcglinn is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Anal Cancer. Dr. Mcglinn is board certified in American Board Of Radiology.
UPMC Altoona Surgery Center Lab
Shabbir Ahmad is a Hematologist practicing medicine in Altoona, Pennsylvania. Dr. Ahmad is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Hemosiderosis, Hemosiderosis, Paget Disease of the Breast, and Pleuropulmonary Blastoma.
UPMC Altoona Surgery Center Lab
Mohammad Alkayem is an Oncologist practicing medicine in Altoona, Pennsylvania. Dr. Alkayem is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Thrombocytopenia, Familial Pancreatic Cancer, and Lung Cancer.
Last Updated: 04/28/2026



